ChemoCentryx to Participate in Two Upcoming Investor Conferences
ChemoCentryx to Participate in Two Upcoming Investor Conferences ChemoCentryx to Participate in Two Upcoming Investor Conferences MOUNTAIN VIEW, Calif., Jan. 06, 2021 — ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that Thomas J. Schall, Ph.D., President and Chief Executive Officer, will present at two upcoming investor conferences and participate in a panel discussion hosted by former FDA Commissioner, Scott Gottlieb, M.D.: 39th Annual J.P. Morgan Healthcare Conference Wednesday, January 13 at 11:40 a.m. Eastern Time H.C. Wainwright Virtual BioConnect Conference On-demand presentat...
Source: globalbankingandfinance.com